Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Jiangsu Jiayi Pharmaceutical Co., Ltd. is a China-based pharmaceutical company specializing in the research, development, and large-scale manufacturing of high-quality generic drugs and active pharmaceutical ingredients (APIs). The company focuses on chronic disease management, particularly in the therapeutic areas of cardiovascular health, metabolic disorders, and endocrinology. Jiayi Pharmaceutical operates modern manufacturing facilities that comply with international GMP standards, enabling it to supply both domestic and global markets. Its product portfolio includes widely used treatments for type 2 diabetes and hypertension, positioning the company as a key player in the Chinese generic drug industry.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Jiangsu Jiayi Pharmaceutical.